abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
94223: Apixaban Print View
Apixaban     ng/mL 

PRIMARY
1 Plasma Citrated 1 (0.5) mL   Frozen - 28 Day(s)  
ALTERNATE

Apixaban is an oral factor Xa inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the treatment, prophylaxis, or the reduction in the risk of recurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE). Apixban does not need to be monitored routinely, however, exceptions may include determination of failure of therapy vs. poor compliance, or potential dose adjustment required for renal or hepatic dysfunction.

Follow current CLSI guidelines for obtaining platelet-poor plasma.
Setup Schedule
Tuesday

Reported (Analytical Time)
Next day

CPT Code
80299

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Methodology: Chromogenic Transport Temperature: Frozen Reject Criteria: Clotted; hemolysis; icteric; grossly lipemic ** This test is not available for New York patient testing **






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database